https://pubmed.ncbi.nlm.nih.gov/36397404/ liver transplant

Medicine (Baltimore). 2022 Nov 11;101(45):e31156.
doi: 10.1097/MD.0000000000031156.

Bone demineralization in a cohort of Egyptian pediatric liver transplant recipients: Single center pilot study

Magd A Kotb 1, Lubna A Fawaz 1, Rania A Zeitoun 2, Yomna M Shaalan 1, Nazira Aly 1, Hesham Abd El Kader 3, Gamal El Tagy 4, Haytham Esmat 4, Alaa F Hamza 3, Hend Abd El Baky 1

Abstract

Liver transplantation (LT) is the definitive treatment of end-stage liver disease. The long-term survival following LT spurred more interest in improving the quality of life of patients. This was a cohort study that included 23 pediatric liver transplant recipients who underwent LT due to hereditary or metabolic liver diseases. Bone health assessment was performed at their last follow up clinically (anthropometric measures), biochemically and radiologically (Dual Energy X-ray Absorptiometry [DEXA] scans). Poor bone health was defined as z-score <-1. Mean age at LT was 5.77 years (standard deviation [SD] 3.64) and 43% were males. Biliary atresia was the most common cause of end stage liver disease (35%). Mean age at follow up was 14 years (SD 5.48) and mean follow up was 8 years (SD 4.12 years). Eleven patients (48%) had poor bone health (osteopenia 22% and osteoporosis 26%). On univariate analysis, being on steroids at last follow up (odds ratio [OR] 13.2, 95% confidence interval [CI] 1.23-140.67, P = .03), weight at last follow up (OR 0.45, 95% CI 0.20-0.99, P = .04), platelets at last follow up (OR 0.98, 95% CI 0.96-s0.99, P = .02), hemoglobin at last follow up (OR 0.33, 95% CI 0.12-0.89, P = .03) were significantly associated with poor bone health. None of the variables were significant on multivariate analysis. At most recent follow up, 48% of patients demonstrated poor bone health by DEXA scans. More studies are required to evaluate predictors of poor bone health after LT in children.

Published on: 
Nov-2022

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: